Value of biomarkers in diagnosis of gastric carcinoma

Clinical and Experimental Medical Letters

Volumn 50, Issue 1, 2009, Pages 1-4

  Luksaite, Renata ^a   Sauer Eppel, Hildegund ^b   Oremek, Gerhard M ^b  

^a VILNIUS UNIVERSITY   (Lithuania)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

CrossLaps; Gastric cancer; Phospholid profile; Tumour markers

Indexed keywords

BIOLOGICAL MARKER; CA 19-9 ANTIGEN; CA 72-4 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; PHOSPHATIDYLETHANOLAMINE; PHOSPHOLIPID; TUMOR MARKER;

ARTICLE; CANCER DIAGNOSIS; CHEMOLUMINESCENCE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ELECTROCHEMICAL ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; METASTASIS; PANCREATITIS; PHOSPHOLIPID MEMBRANE; PREOPERATIVE EVALUATION; PROGNOSIS; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; STOMACH CARCINOMA; STOMACH ULCER;

EID: 77953406629     PISSN: 18952089     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Posner MR, Mayer RJ. The use of serologic tumor markers in gastrointestinal malignancies. Hematol Oncol Clin Noth Am 1994; 8: 833-853
2. Black RJ, Bray F, Ferlay J, Parkin DM. Cancer incidence and mortality in the European Union: Cancer registry data and estimates of national incidence for 1990. Eur J Cancer 1997; 33: 1075-1107
3. Akoh JA, Macintyre IMC. Improving survival in gastric cancer review of 5-year survival rates in Enlish language publications from 1970. Br J Surg 1992; 79: 293-299
4. Nakane Y, Okamura S, Akehira K, Boku T, Okusa T, Tanaka K, et al. Correlation of preoperative carcinoembryonic antigen levels and prognosis of gastric cancer patients. Cancer 1994; 73: 2703-2708 (Pubitemid 24166254)
5. Moertel CG, O'Fallon JR, Go VLW, O'Connell MJ, Thynne GS. The preoperative carcinoembryonic antigen test in diagnosis, staging and prognosis of colorectal cancer. Cancer 1986; 58: 603-610 (Pubitemid 16072059)
6. Gaspar MJ, Arribas I, Coca MC, Diez-Alonso M. Prognostic Value of Carcinoembryonic Antigen, CA 19-9 and CA 72-4 in Gastric Carcinoma. Tumor Biol 2001; 22: 318-322 (Pubitemid 32823950)
7. Kornek G, Depisch D, Temsch EM, Scheithauer W. Comparative analysis of cancer-associated antigen CA-195, CA 19-9 and carcinoembryonic antigen in diagnosis, follow-up and monitoring to response to chemotherapy in patients with gastrointestinal cancer. J Cancer Res Clin Oncol 1991; 117: 493-496
8. Barillari P, Sammartino P, Cardi M, Ricci M, Gozzo P, Cesareo S, et al. Gastrointestinal cancer follow-up: The effectiveness of sequential CEA, TPA and CA 19-9 evaluation in the early diagnosis of recurrences. Aust N Z J Surg 1991; 61: 675-680
9. Johnson VG, Schlom J, Paterson AJ, Bennet J, Magnani JL, Colcher D. Analysis of a human tumor-associated glycoprotein (TAG-72) identified by monoclonal antibody B 72.3. Cancer Res 1986; 46: 850-857 (Pubitemid 16145448)
10. Hamazoe R, Maeta M, Matsui T, Shibata S, Shiota S, Kaibara N. CA 72-4 compared with carcinoembryonic antigen as a tumor marker for gastric cancer. Eur J Cancer 1992; 28A: 1351-1354
11. Thor A, Ohuchi N, Szpak CA, Johnston WW, Schlom J. Distribution of oncofetal antigen tumor-associated glycoprtein-72 defined by monoclonal antibody B 72.3. Cancer Res 1986; 46: 3118-3124 (Pubitemid 16074337)
12. Joypaul B, Browning M, Newman E, Byrne D, Cuschierei A. Comparison of serum CA 72-4 and CA 19-9 levels in gastric cancer patients and correlation with recurrence. Am J Surg 1995; 169: 595-599
13. Spila A, Roselli M, Cosimelli M, Ferroni P, Cavaliere F, Arcuri R, et al. Clinical utility of CA 72-4 serum marker in the staging and immediate postsurgical management of gastric cancer patients. Anticancer Res 1996; 16: 2241-2248 (Pubitemid 26265572)
14. Safi F, Kuhns V, Berger HG. Comparison of CA 72-4, CA 19-9 and CEA in the diagnosis and monitoring of gastric cancer. Int J Biol Markers 1995; 10: 100-106
15. Kodera Y, Yamamura Y, Torii A, Uesaka K, Hirai T, Yasui K, et al. The prognostic value of preoperative serum levels of CEA and CA 19-9 in patients with gastric cancer. Am J Gstroenterol 1996; 91: 49-53. (Pubitemid 26026036)
16. Rosenquist C, Fledelius C, Christgau S, Pedersen BJ, Bonde M, Qvist P, et al. The serum CrossLaps One Step ELISA. The first quantitative determination in serum of degradation products from C-terminal telopeptides of type I collagen from bone using monoclonal antibodies. Clin Chem 1998; 44: 2293-2301 (Pubitemid 28511750)
17. Spila A, Roselli M, Cosimelli M, Ferroni P, Cavaliere F, Arcuri R, et al. Clinical utility of CA 72-4 serum marker in the staging and immediate postsurgical management of gastric cancer patients. Anticancer Res 1996; 16: 2241-2248 (Pubitemid 26265572)
18. Kodera Y, Yamamura Y, Torii A, Uesaka K, Hirai T, Yasui K, et al. The prognostic value of preoperative serum levels of CEA and CA 19-9 in patients with gastric cancer. Am J Gastroenterol 1996; 91: 49-53. (Pubitemid 26026036)
19. Victorzon M, Haglund C, Lundin J, Roberts PJ. A prognostic value of CA 19-9 but not of CEA in patients with gastric cancer. Eur J Surg Oncol 1995; 21: 379-384
20. Nakane Y, Okamura S, Akehira K, Boku T, Okusa T, Tanaka K, et al. Correlation of preoperative carcinoembryonic antigen levels and prognosis of gastric cancer patients. Cancer 1994; 73: 2973-2978 (Pubitemid 24166254)
21. Sakamoto J, Nakazato H, Teramukai S, Ohashi Y, Takahashi Y, Mai M, et al. Association between preoperative plasma CEA levels and the prognosis of gastric cancer following curative resection. Tumor Marker Committee, Japanese Foundation for Multidisciplinary Treatment of Cancer, Tokyo, Japan. Surg Oncol 1996; 5: 133-213
22. Ikeda Y, Mori M, Kajiyama K, Kamakura T, Maehara Y, Haraguchi Y, et al. Indicative value of carcinoembryonic antigen (CEA) for liver recurrence following curative resection of stage II and III gastric cancer. Hepatogastroenterology 1996; 43: 1281-1287 (Pubitemid 26358526)
23. Yogeenwaran, Salk Pl. Metastatic potential is positively correlated with cell surface sialylation of cultured murine tumor sell lines. Science 1981; 212: 1514-1517
24. Nakamura T, Tabuchi Y, Nakae S, Ohno M, Saitoh Y. Serum carcinoembryonic antigen levels and proliferating cell nuclear antigen labeling index for patients with colorectal carcinoma. Cancer 1996; 77: 1741-1746